Late Breaking Abstract - The use of a digital inhalation coach reduces inhalation error rates in a clinical trial.

<bold>Background:</bold> Inhalation errors are a common source of underdosing in asthma patients, leading to poor asthma control. Thus, regular inhalation training is recommended. The Kata<sup>®</sup> app is a digital inhalation coach that provides step-by-step guidance on how to inhale correctly. <bold>Objective:</bold> Evaluate the effect of the Kata<sup>®</sup> app on inhalation technique and clinical endpoints (e.g., FeNO; ACQ-5) in a clinical trial. <bold>Methods:</bold> This post hoc analysis of Kata<sup>®</sup> app data collected during a phase II randomized controlled trial, included adult patients with moderate to severe, uncontrolled type-2 high asthma (N=78). Patients were followed for up to 12 weeks. A smartphone with the Kata<sup>®</sup> app was provided at study start. Patients were asked to record each inhalation of their asthma maintenance treatment. Inhalation errors were scored according to predefined criteria. Rates for total and critical errors (significantly affect drug delivery) were calculated as the number of errors per inhalation. Analysis of clinical endpoints used data from the run-in phase only. <bold>Results:</bold> Univariate regression analysis showed a significant total error rate decrease of 1.4% per study day (p<.001; 95%CI: 0.8-1.9). Similarly, a significant decrease of the critical error rate of 2.0% per study day was found (p<.001; 95%CI: 1.0-2.6). There was a significant improvement of the ACQ-5 (p=.036; N=59). No significant improvement of FeNO was found (p=.170; N=60), but 26 of 60 patients (43%) showed a clinically relevant decrease (>20%) of FeNO. <bold>Conclusion:</bold> The Kata<sup>®</sup> app improves inhalation technique in a clinical trial and is associated with improved asthma control. The Kata<sup>®</sup> app is a useful tool for patients using inhalers to treat their asthma.

Authors

Institutions

Publication Details

Published
2024-09-14
DOI
https://doi.org/10.1183/13993003.congress-2024.pa797
Primary Topic
Inhalation and Respiratory Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Late Breaking Abstract - The use of a digital inhalation coach reduces inhalation error rates in a clinical trial.

Kai Michael Beeh, Michael C. Meyer, Philipp Kroneberg, Laura J. Arendsen et al.
Inhalation and Respiratory Drug Delivery
article

Late Breaking Abstract - The use of a digital inhalation coach reduces inhalation error rates in a clinical trial.

Kai Michael Beeh, Michael C. Meyer, Philipp Kroneberg, Laura J. Arendsen, Marion Wencker
article en

Abstract

<bold>Background:</bold> Inhalation errors are a common source of underdosing in asthma patients, leading to poor asthma control. Thus, regular inhalation training is recommended. The Kata<sup>®</sup> app is a digital inhalation coach that provides step-by-step guidance on how to inhale correctly. <bold>Objective:</bold> Evaluate the effect of the Kata<sup>®</sup> app on inhalation technique and clinical endpoints (e.g., FeNO; ACQ-5) in a clinical trial. <bold>Methods:</bold> This post hoc analysis of Kata<sup>®</sup> app data collected during a phase II randomized controlled trial, included adult patients with moderate to severe, uncontrolled type-2 high asthma (N=78). Patients were followed for up to 12 weeks. A smartphone with the Kata<sup>®</sup> app was provided at study start. Patients were asked to record each inhalation of their asthma maintenance treatment. Inhalation errors were scored according to predefined criteria. Rates for total and critical errors (significantly affect drug delivery) were calculated as the number of errors per inhalation. Analysis of clinical endpoints used data from the run-in phase only. <bold>Results:</bold> Univariate regression analysis showed a significant total error rate decrease of 1.4% per study day (p<.001; 95%CI: 0.8-1.9). Similarly, a significant decrease of the critical error rate of 2.0% per study day was found (p<.001; 95%CI: 1.0-2.6). There was a significant improvement of the ACQ-5 (p=.036; N=59). No significant improvement of FeNO was found (p=.170; N=60), but 26 of 60 patients (43%) showed a clinically relevant decrease (>20%) of FeNO. <bold>Conclusion:</bold> The Kata<sup>®</sup> app improves inhalation technique in a clinical trial and is associated with improved asthma control. The Kata<sup>®</sup> app is a useful tool for patients using inhalers to treat their asthma.

Respiratory Research Institute (DE), Institut für Angewandte Statistik (DE), LaVision (Germany) (DE), Refonet (DE)
Openalex Percentile: Top 63%
Inhalation and Respiratory Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.